Prehospital plasma: Not a done deal just yet!
- Tag: administration, bleeding, coagulation, critical care, emergency, hemodynamics, mortality, normal distribution, PAMPer, plasma, Prehospital, TBI, transfusion, trauma
- 2 Comments
Our Society has pulled off what I have always wanted. We have managed to have two intellectually satisfying editorials on a challenging subject, such as the prehospital administration of plasma. Last month, Dr. Dante Yeh summarized and explained how the PAMPer study justifies the administration of plasma in the prehospital study. It is a randomized control study with a positive mortality benefit. It was also logistically complex to conduct, and so it is highly unlikely that any other study will be able to perform such a trial again. However, if you thought the verdict was out, Dr. Kevin Blaine has written a response to Dr. Yeh editorial. His powerful arguments have left me in a conundrum, “Should we be administering plasma in the prehospital setting?” I am excited to see your responses after you read it for yourself.
Dr Blaine is a trauma anesthesiologist, intensivist, and Assistant Professor at the Keck School of Medicine of the University of Southern California. With a background in clinical trials, his current research interests include acute traumatic coagulopathy and next-generation coagulation tests.